Blood Pressure Test Market Analysis

Global Blood Pressure Test Market Overview

The Blood Pressure Test Market Size was valued at USD 1.80 Billion in 2023. The Global Blood Pressure Test industry is projected to grow from USD 1.99 Billion in 2024 to USD 4.15 Billion by 2032, exhibiting a compound annual growth rate (CAGR) of 8.48% during the forecast period (2024 - 2032). Blood pressure is a measure of the amount of blood pushed against the walls of the arteries. It is namely of two types; systolic pressure and diastolic pressure and is measured in millimeters of mercury (mm Hg). Blood pressure test usually is done to diagnose hypertension, one of the major risk factor for coronary heart disease. It can be done at hospitals, clinics, and diagnostic centers, to determine the elevation in the blood pressure in case of an emergency. Blood pressure test can also be done at home with numerous blood pressure testing devices available in the market.

In January 2024, Movano Health had released outcomes of its blood tension clinical study sanctioned by the Institutional Review Board (IRB). The company’s prototype with integrated System-on-Chip (SoC) has reached the accuracy level required by the Food and Drug Administration (FDA) for blood pressure monitoring devices.

In August 2023, Spacelabs Healthcare took part in the AHA’s Hypertension Scientific Sessions 2023. The firm stated how vital 24-hour ambulatory blood pressure monitoring is to managing hypertension better than any other method as it enables more accurate prediction of heart and vascular diseases, morbidity as well as mortality rates.

Valencell announced plans to introduce a line of branded products under the digital health category during its announcement in January 2023, justifying it as an innovative way to bring reverse solutions for chronic diseases. Valencell will also be the first cuff-less, calibration-free blood pressure monitor that can fit on a fingertip on Earth. This solution may be applied independently as a BP monitor. However, when used together with an app, this device is anticipated to have significant importance in HTN control.

For example, InBody introduced the new automatic BP monitor BP170 allowing self-recording and tracking of key health measurements at home during February 2022. Similarly, increasing adoption of home care health monitoring along with an increased focus on early diagnosis of hypertension & cardiac diseases is further expected to push up growth in the market.

Hillrom acquired contact-free continuous monitoring technology from EarlySense at a sum of $30 million dollars, according to the company’s announcement last year around February. Consequently, this acquisition will enable Hillrom to develop next-gen AI-based sensing technologies specifically designed for remote patient care business.

Biobeat launched wearable chest-mounted continuous ABPM systems this May 1.

In February 2020, Hillrom announced the commercial release of a new device called Welch Allyn Spot Vital Signs 4400, which is an easy-to-use next-generation vital signs monitor used to enhance hypertension detection in ambulatory & emergency department settings.

Blood Pressure Test Market Trends

The blood pressure test market is driven by rising prevalence of chronic diseases such as cardiovascular diseases, hypertension, diabetes, and others. Furthermore, changing lifestyle, and increasing demand for diagnostic devices for cardiovascular diseases is facilitating the market growth. However, a limited number of trained personnel has restrained the growth of the market. However, the high cost of diagnosis and treatment of cardiovascular diseases restrains the growth of the market.

According to the WHO, about 59% of the mortality is due to chronic diseases, and almost 35 million people die of chronic diseases in the world. Cardiovascular diseases and diabetes are increasing the economic burden of various developing and developed nations across the globe.

Intended Audience

• Medical Device Manufacturers


• Medical Device Suppliers


• Medical Research Laboratories


• Research and Development (R&D) Companies


• Market Research and Consulting Service Providers


• Potential Investors

Blood Pressure Test Market Segment Insights

The blood pressure test market is segmented on the basis of product, indication, and end user.

On the basis of the product, the blood pressure test market is segmented into sphygmomanometers, blood pressure transducers, blood pressure instrument accessories, and others.

Sphygmomanometers is further segmented into mercury, aneroid and digital. Blood pressure transducers is further segmented into disposable and reusable. Blood pressure instrument accessories is further segmented into blood pressure cuffs, bladders, and bulbs & valve.

On the basis of indication, the blood pressure test market is segmented into hypertension, coronary heart disease, and others.

On the basis of the end user, the blood pressure test market is segmented into hospitals & clinics, diagnostic centers, home care and others.

Blood Pressure Test Regional Insights      

The Americas account for the largest blood pressure test market. Increasing prevalence of cardiovascular diseases and diabetes is the major driving factor for the growth of the market. According to the Center for Diseases Control and Prevention (CDC), 9.3% of the total American population is suffering from diabetes. Increasing number of diabetic and obese population, rising demand for better treatment for the diseases and well-developed infrastructure has provided fuel for the growth of the market. North America accounts for the major share in the America advanced blood pressure test market.

Europe accounts for the second largest market due to the well-developed healthcare sector, continuously increasing patient population, and high healthcare expenditure. Additionally, increasing prevalence of diabetes in the European Union (EU) also fuels the market growth. Germany, the U.K., and France hold the first, second and third position in the market.

Asia Pacific is expecting the fastest growth for this market. Increasing prevalence of cardiovascular diseases and rising geriatric population are the major driving factor for the growth of the market. India and China are the two major regions with the highest contribution to the market growth owing to highest diabetic population and increasing the presence of heart attack among these patients. Additionally, rising geriatric population further drive the growth of the market. Furthermore, rapid development of the healthcare infrastructure also accelerates the market growth. According to the International diabetic federation, India and China account 180 million people have diabetes which is approximately 40% of world’s diabetic population. The rising prevalence of diabetes in this region is attributed to rising prevalence of lifestyle disorders such as obesity, and addiction such as smoking. According to the International Diabetes Foundation, 98.4 million and 65.1 million diabetic population live in China and India respectively.

In the Middle East & Africa, the market is expected to show steady growth due to developing healthcare system, and increasing demand for diagnostic and treatment services. The Middle East is the major contributor to the market which is driven by the presence of well-developed economies such as Kuwait and Qatar. Whereas, Africa exhibits slow growth due to limited development in the field of medical science and presence of poor economic conditions in various developing regions of Africa.

Key Players in the Blood Pressure Test Market

Some of the key players in blood pressure test market are 

• OMRON Corporation


• SunTech Medical, Inc.


• SPENGLER


• Schiller AG


• Spacelabs Healthcare


• American Diagnostic Corporation


• Bosch + Sohn GmbH u. Co. KG


• Withings SA, Welch Allyn, Inc


• A&D Medical


• Koninklijke Philips N.V.


• General Electric Company